Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Donald Berwick Institute for Healthcare
Improvement, 375 Longwood Avenue, Boston, MA 02215, USA dberwick@ihi.org
| The first 150 words of the full text of this article appear below. |
An editorial last year in the Washington Post challenged directors of drug companies to reduce the cost of HIV drugs in poor countries to zero. Here the reproduced editorial is accompanied by a discussion about why it was written and the response to it. We invited comment from one of the named directors and from a man with AIDS who refuses to take antiretroviral drugs until they are available to the public sector in South Africa
Last year I wrote a guest editorial for the Washington Post in which I challenged the world's pharmaceutical companies to cut the cost of HIV drugs to zero in poor countries (see box on next page).1 Here I explain why I wrote it and describe some of the responses it provoked.
| Table Removed (Available Only in the Full Text) |
| |
The prologue |
|---|
People living in poverty being denied access to modern health care
is a form of violent, systematic social deprivation that we, as a
Read all Rapid Responses